These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26924198)

  • 1. [Treatment of cardiovascular risk factors].
    Krüger K
    Z Rheumatol; 2016 Mar; 75(2):173-80; quiz 181-2. PubMed ID: 26924198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Krüger K
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1773-1774. PubMed ID: 29145683
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiovascular comorbidities in rheumatoid arthritis].
    Krüger K; Nüßlein H
    Z Rheumatol; 2019 Apr; 78(3):221-227. PubMed ID: 30656399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologics].
    Kalden JR
    Z Rheumatol; 2016 Aug; 75(6):604-10. PubMed ID: 27365024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Korsten P; Müller GA
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1775-1777. PubMed ID: 29145684
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coxibs].
    Bolten WW; Krüger K
    Z Rheumatol; 2016 Aug; 75(6):595-8. PubMed ID: 27418054
    [No Abstract]   [Full Text] [Related]  

  • 7. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis?
    Pieringer H; Pichler M; Pohanka E; Hoppe UC
    Curr Pharm Des; 2014; 20(4):486-95. PubMed ID: 23565635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge].
    Krüger K; Edelmann E
    Z Rheumatol; 2015 Jun; 74(5):414-20. PubMed ID: 26085073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs.
    Chatterjee S; Sarkate P; Ghosh S; Biswas M; Ghosh A
    J Assoc Physicians India; 2013 Aug; 61(8):531-4. PubMed ID: 24818335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
    Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
    Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.
    Gasparyan AY; Ayvazyan L; Cocco G; Kitas GD
    Curr Pharm Des; 2012; 18(11):1543-55. PubMed ID: 22364138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rheumatoid arthritis].
    Aletaha D; Kerschbaumer A
    Z Rheumatol; 2017 Feb; 76(1):8-14. PubMed ID: 28058499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucocorticoids].
    Gromnica-Ihle E
    Z Rheumatol; 2016 Aug; 75(6):591-4. PubMed ID: 27412667
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comorbidities-Their role in the treat to target concept for rheumatoid arthritis].
    Krüger K; Kneitz C
    Z Rheumatol; 2019 Jun; 78(5):422-428. PubMed ID: 31049664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underestimation of the efficacy, effectiveness, tolerability, and safety of weekly low-dose methotrexate in information presented to physicians and patients.
    Pincus T; Furer V; Sokka T
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S68-79. PubMed ID: 21044437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis.
    Di Minno MN; Iervolino S; Lupoli R; Russolillo A; Coppola A; Peluso R; Scarpa R; Di Minno G
    Semin Thromb Hemost; 2012 Jul; 38(5):497-505. PubMed ID: 22399309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular disease in rheumatic diseases].
    Nasonov EL; Popkova TV; Novikova DS
    Ter Arkh; 2016; 88(5):4-12. PubMed ID: 27458622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biologics and cardiovascular risk].
    Tarner IH; Müller-Ladner U; Hamm C
    Z Rheumatol; 2010 Oct; 69(8):702-6, 708-11. PubMed ID: 20862482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid therapy in rheumatoid arthritis - pro].
    Pongratz G
    Dtsch Med Wochenschr; 2016 Oct; 141(22):1650. PubMed ID: 27824423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.